| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Animal Model |
From the Laboratoire de Neuropathologie,*Centre Hospitalier Regional Universitaire (CHRU), Lille, France; Equipe Accueil 2691,Faculté de Médecine, Lille, France; Equipe Mixte INSERM 99-21,Faculté de Médecine Lariboisière, Paris, France; and the Laboratoire de Cytogénétique,Hôpital Lariboisière, Paris, France
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an increasingly recognized adult-onset autosomal dominant vascular dementia, caused by highly stereotyped mutations in the Notch3 receptor. CADASIL is a widespread angiopathy characterized by a degeneration of vascular smooth muscle cells (VSMCs) and the abnormal accumulation of electron-dense granular material called GOM and Notch3 protein, because of an impaired clearance. Evidence that VSMCs are the primary target of the pathogenic process is supported by the restricted expression of Notch3 in these cells but mechanisms of their degeneration remain essentially unknown. We generated transgenic mice in which the SM22
promoter drove, in VSMCs, the expression of a full-length human Notch3 carrying the Arg90Cys mutation, a CADASIL archetypal mutation. Transgenic mice showed no evidence of prominent brain parenchyma damage but demonstrated the two hallmarks of the CADASIL angiopathy, GOM deposits and Notch3 accumulation, within both the cerebral and peripheral arteries. Of interest, arteries of the tail were more severely affected with prominent signs of VSMC degeneration. Time-course analysis of vessel changes revealed that disruption of normal VSMC anchorage to adjacent extracellular matrix and cells, VSMC cytoskeleton changes as well as starting signs of VSMC degeneration, which were detected around 10 months of age, preceded Notch3 and GOM accumulation appearance, which were observed only by 14 to 16 months of age. In conclusion, we have generated transgenic mice that recapitulate the characteristic vascular lesions observed in CADASIL. Our results indicate that Notch3 or GOM accumulation are unlikely to be the prerequisites for the induction of VSMC degeneration and suggest that degeneration of VSMCs may rather be triggered by the disruption of their normal anchorage, based on the important role of adhesion for cell survival.
This article has been cited by other articles:
 |
|
 |
|
  S. Weinsheimer, G. M. Lenk, M. van der Voet, S. Land, A. Ronkainen, I. Alafuzoff, H. Kuivaniemi, and G. Tromp Integration of expression profiles and genetic mapping data to identify candidate genes in intracranial aneurysm Physiol Genomics, December 19, 2007; 32(1): 45 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Roca and R. H. Adams Regulation of vascular morphogenesis by Notch signaling Genes & Dev., October 15, 2007; 21(20): 2511 - 2524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Gridley Notch signaling in vascular development and physiology Development, August 1, 2007; 134(15): 2709 - 2718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Niessen and A. Karsan Notch signaling in the developing cardiovascular system Am J Physiol Cell Physiol, July 1, 2007; 293(1): C1 - C11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Hofmann and M. L. Iruela-Arispe Notch Signaling in Blood Vessels: Who Is Talking to Whom About What? Circ. Res., June 8, 2007; 100(11): 1556 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Monet, V. Domenga, B. Lemaire, C. Souilhol, F. Langa, C. Babinet, T. Gridley, E. Tournier-Lasserve, M. Cohen-Tannoudji, and A. Joutel The archetypal R90C CADASIL-NOTCH3 mutation retains NOTCH3 function in vivo Hum. Mol. Genet., April 15, 2007; 16(8): 982 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, E. Calvo, M. Cool, P. Chrobak, D. G. Kay, and P. Jolicoeur Overexpression of Notch1 Ectodomain in Myeloid Cells Induces Vascular Malformations through a Paracrine Pathway Am. J. Pathol., January 1, 2007; 170(1): 399 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Hachinski, C. Iadecola, R. C. Petersen, M. M. Breteler, D. L. Nyenhuis, S. E. Black, W. J. Powers, C. DeCarli, J. G. Merino, R. N. Kalaria, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Stroke, September 1, 2006; 37(9): 2220 - 2241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. G. Leblanc, J. F. Meschia, D. T. Stuss, and V. Hachinski Genetics of Vascular Cognitive Impairment: The Opportunity and the Challenges Stroke, January 1, 2006; 37(1): 248 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Haritunians, T Chow, R P J De Lange, J T Nichols, D Ghavimi, N Dorrani, D M St Clair, G Weinmaster, and C Schanen Functional analysis of a recurrent missense mutation in Notch3 in CADASIL J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1242 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lacombe, C. Oligo, V. Domenga, E. Tournier-Lasserve, and A. Joutel Impaired Cerebral Vasoreactivity in a Transgenic Mouse Model of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Arteriopathy Stroke, May 1, 2005; 36(5): 1053 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A V MacLean, R Woods, L M Alderson, S P Salloway, S Correia, S Cortez, and E G Stopa Spontaneous lobar haemorrhage in CADASIL J. Neurol. Neurosurg. Psychiatry, March 1, 2005; 76(3): 456 - 457. [Full Text] [PDF]
|
|
|
|
|
|
C. Dubroca, P. Lacombe, V. Domenga, J. Maciazek, B. Levy, E. Tournier-Lasserve, A. Joutel, and D. Henrion Impaired Vascular Mechanotransduction in a Transgenic Mouse Model of CADASIL Arteriopathy Stroke, January 1, 2005; 36(1): 113 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Domenga, P. Fardoux, P. Lacombe, M. Monet, J. Maciazek, L. T. Krebs, B. Klonjkowski, E. Berrou, M. Mericskay, Z. Li, et al. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells Genes & Dev., November 15, 2004; 18(22): 2730 - 2735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Astrof, D. Crowley, E. L. George, T. Fukuda, K. Sekiguchi, D. Hanahan, and R. O. Hynes Direct Test of Potential Roles of EIIIA and EIIIB Alternatively Spliced Segments of Fibronectin in Physiological and Tumor Angiogenesis Mol. Cell. Biol., October 1, 2004; 24(19): 8662 - 8670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Tille and M.S. Pepper Hereditary Vascular Anomalies: New Insights Into Their Pathogenesis Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1578 - 1590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mazzei, F. L. Conforti, P. L. Lanza, T. Sprovieri, M. R. Lupo, O. Gallo, A. Patitucci, A. Magariello, M. Caracciolo, A. L. Gabriele, et al. A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL Neurology, August 10, 2004; 63(3): 561 - 564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fischer, N. Schumacher, M. Maier, M. Sendtner, and M. Gessler The Notch target genes Hey1 and Hey2 are required for embryonic vascular development Genes & Dev., April 15, 2004; 18(8): 901 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Hussain, S. Singhal, H. S. Markus, and D. R.J. Singer Abnormal Vasoconstrictor Responses to Angiotensin II and Noradrenaline in Isolated Small Arteries From Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Stroke, April 1, 2004; 35(4): 853 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Alberts Genetics of Cerebrovascular Disease Stroke, February 1, 2004; 35(2): 342 - 344. [Full Text] [PDF]
|
|
|
|
|
|
T. Gridley Notch signaling and inherited disease syndromes Hum. Mol. Genet., April 2, 2003; 12(90001): R9 - 13. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
